Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 2, Number 4—October 1996
Dispatch

Rapid Increase of Resistance to Erythromycin and Clindamycin in Streptococcus pyogenes in Italy, 1993-1995

Giuseppe Cornaglia*, Marco Ligozzi*, Annarita Mazzariol*, Myriam Valentini*, Graziella Orefici†, Roberta Fontana*, and ‡the Italian Surveillance Group for Antimicrobial Resistance
Author affiliations: *Institute of Microbiology, University of Verona, Italy; †National Health Institute, Rome, Italy; ‡The Italian Surveillance Group for Antimicrobial Resistance: Antonio Goglio, Cristiana Passerini Tosi, Ospedali Riuniti di Bergamo; Massimo Gallina, Panaiota Troupioti, Azienda Ospedaliera 'Morelli’, Bormio; Bruno Maranini, Riccardo Cioni, Ospedale 'San Giuseppe’ Empoli; Pierluigi Nicoletti, Laura Martelli, Azienda Ospedaliera 'Careggi', Florence, Sergio Frugoni, Amelia Berlusconi, Pio Albergo Trivulzio, Milan; Roberto Rescaldani, Simone Bramati, Ospedale 'San Gerardo', Monza; Alfredo Chiarini, Anna Giammanco, Dipartimento di Igiene e Microbiologia, Università di Palermo; Roberto Rossetti, Spedali Riuniti, Pistoia; Gianfranco Santini, Annapaola Callegaro, Ospedale Civile, Pordenone; Giovanni Fadda, Teresa Spanu, Istituto di Microbiologia, Università Cattolica del Sacro Cuore, Rome; Alessandro Maida, Elena Muresu, Bianca Maria Are, Istituto di Igiene e Medicina Preventiva, Università di Sassari; Piero Cappuccinelli, Silvana

Main Article

Table

Antibiotic susceptibilities,* presence of the ermAM gene, pulse-field gel electrophoresis type, and T-protein pattern of Streptococcus pyogenes strains isolated in Verona

Strain ERY† MIO‡ CLI§ ermAM PFGE type T-protein pattern
VR1 R S S - A 8, 25
VR2 R S S - A 8, 25
VR3 R S S - A 25
VR4 R S S - A 8, 25
VR5 R R R + B 2, 28
VR6 R R R + C 5, 12, 27
VR7 R S S - D 4
VR8 R R R + C 12, 27
VR9 R R R + E 5, 12, 27
VR10 R R R + B 2
VR11 R R R + C 12, 27
VR13 R R R + C 5, 12, 27
VR14 R R R + C 12, 27
VR15 R R R + C 5, 12, 27

*Resistant, susceptible
†Erythromycin
‡Miokamycin
§Clindamycin

Main Article

Page created: December 21, 2010
Page updated: December 21, 2010
Page reviewed: December 21, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external